With the acquisition of DIARECT GmbH in June 2021, significant new product lines and skills have been added which considerably strengthens the BBI Solutions reagents portfolio. We offer a range of autoimmune, allergy and specific infectious disease antigen products, in addition to a range of Surmodics stabilisers, blockers and substrates.
Our core competencies include a comprehensive suite of reagents with custom development options, lateral flow development and diagnostic manufacturing services.
Each site follows strict Quality Control and product release protocols, which coupled with effective Quality Assurance processes ensure our products meet stringent product quality, safety and customer requirements.
Innovation is at the heart of our operations. The extensive breadth and depth of our products and services portfolio is testimony to the ongoing investment in our people and facilities.
BBI Solutions has been serving the global diagnostics industry for over 30 years and is the world’s largest independent producer of immuno-diagnostics reagents.
